Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 3, 2017, Pages

  Usmani, Zafar A ^a,b   Carson, Kristin V ^b   Heslop, Karen ^c   Esterman, Adrian J ^d   De Soyza, Anthony ^e   Smith, Brian J ^b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCEPTANCE AND COMMITMENT THERAPY; ANXIETY; ANXIETY DISORDER; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; DISABILITY; DYSPNEA; EMOTION; EXERCISE TOLERANCE; GROUP THERAPY; HUMAN; INTERMETHOD COMPARISON; MINDFULNESS; MINDFULNESS BASED COGNITIVE THERAPY; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOTHERAPY; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SHORT FORM 36; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ANXIETY DISORDERS; CHRONIC BRONCHITIS; EMPHYSEMA; FEMALE; MALE; META ANALYSIS; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANXIETY DISORDERS; BRONCHITIS, CHRONIC; EMPHYSEMA; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; PSYCHOTHERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85015798365     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010673.pub2     Document Type: Review

References (102)

1. de Godoy DV, de Godoy RF. A randomised controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Archives of Physical Medicine and Rehabilitation 2003;84(8):1154-7. 5322060
2. Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomised controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respiratory Medicine 2010;104:986-94. 5322062
3. Nordhus IH. Cognitive Behavioral Therapy for Anxiety and Depression in COPD. clinicaltrials.gov/ct2/show/NCT00545922 2007. 5322063
4. Kunik ME, DeBakey ME. A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD. clinicaltrials.gov/ct2/show/NCT00105911 2005. 5322065
5. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomised controlled trial. Psychological Medicine 2008;38:385-96. 5322066
6. Aubuchon BL. The effects of positive mental imagery on hope, coping, anxiety, dyspnea and pulmonary function in persons with chronic obstructive pulmonary disease: tests of a nursing intervention and a theoretical model [Dissertation]. Austin (USA): The University of Texas at Austin, 1990. 5322068
7. Blake RL Jr, Vandiver TA, Braun S, Bertuso DD, Straub V. A randomised controlled evaluation of a psychosocial intervention in adults with chronic lung disease. Family Medicine 1990;22(5):365-70. 5322070
8. Blumenthal JA, Emery CF, Smith PJ, Keefe FJ, Welty-Wolf K, Mabe S, et al. The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study. Psychosomatic Medicine 2014;76:581-92. 5322072
9. Cully J. Transforming Psychotherapy for Chronically Ill Patients. clinicaltrials.gov/ct2/show/NCT00520429 2007. 5322074
10. de Godoy DV, de Godoy RF, Junior BB, Vaccari PF, Michelli M, Teixeira PJZ. The effect of psychotherapy provided as part of a pulmonary rehabilitation program for the treatment of patients with chronic obstructive pulmonary disease. Jornal Brasileiro de Pneumologia 2005;31(6):499-505. 5322076
11. Doyle T, Palmer S, Johnson J, Babyak M, Smith P, Mabe S. Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. International Journal of Psychiatry in Medicine 2013;45(2):189-202. 5322078
12. Gift AG, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nursing Research 1992;41(4):242-6. 5322080
13. Lamers F, Jonkers CCM, Bosma H, Chavannes NH, Knottnerus JA, Van Eijk JT. Improving quality of life in depressed COPD patients: Effectiveness of a minimal psychological intervention. COPD: Journal of Chronic Obstructive Pulmonary Disease 2010;7(5):315-22. 5322082
14. Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in COPD. European Respiratory Journal 2010;35(3):554-63. 5322084
15. Lolak S, Connors G, Sheridan M, Shumway J, Hess S, Farrell S. Effects of progressive relaxation on depression and anxiety in COPD patients. 158th Annual Meeting of the American Psychiatric Association. 2005. 5322086
16. Lolak S, Connors GL, Sheridan MJ, Wise TN. Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychotherapy and Psychosomatics 2008;77(2):119-25. 5322087
17. Pommer AM, Pouwer F, Denollet J, Pop VJM. Managing co-morbid depression and anxiety in primary care patients with asthma and/or chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. Trials 2012;13:6. 5322089
18. Pouwer F, Stoop CH. Disease management of depression and anxiety (DiMaCoDeA) in primary care patients with diabetes mellitus, asthma and/or COPD. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2626 2010. 5322090
19. Williams M. Can changing the way people with chronic lung disease think about breathlessness improve and sustain health outcomes?. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=336473 2011. 5322092
20. Yang T. Evaluation, Psychological Intervention and Follow-up Study of Anxiety and Depression in Stable Chronic Obstructive Pulmonary Disease Patients. clinicaltrials.gov/ct2/show/NCT02413840 2015. 5322094
21. Bove DG. Dialogue aimed at reducing anxiety in patients with severe COPD (DIACOL). clinicaltrials.gov/ct2/show/NCT02366390 2015. 5322097
22. Bove DG, Overgaard D, Lomborg K, Lindhardt BO, Midtgaard J. Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol. BMJ Open 2015;5:e008031. 5322096
23. Cully JA, Armento ME, Mott J, Nadorff MR, Naik AD, Stanley MA. Brief cognitive behavioral therapy in primary care: a hybrid type 2 patient-randomised effectiveness-implementation design. Implementation Science 2012;7:64. 5322099
24. Farver-Vestergaard I. Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease. clinicaltrials.gov/ct2/show/NCT02042976 2014. 5322101
25. Heslop K. A single centre randomised controlled trial to identify if cognitive behavioural therapy delivered by respiratory nurses reduces anxiety and depression in patients with chronic obstructive pulmonary disease (CBT CARE Study). www.isrctn.com/ISRCTN55206395 2011. 5322104
26. Heslop K, Newton J, Baker C, Burns G, Carrick-Sen D, De Soyza A. Effectiveness of cognitive behavioural therapy (CBT) interventions for anxiety in patients with chronic obstructive pulmonary disease (COPD) undertaken by respiratory nurses: the COPD CBT CARE study: (ISRCTN55206395). BMC Pulmonary Medicine 2013;13:62-8. 5322103
27. Livermore N, Dimitri A, Sharpe L, McKenzie DK, Gandevia SC, Butler JE. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respiratory Physiology & Neurobiology 2015;216:35-42. 5322106
28. Phan T, Carter O, Waterer G, Braithwaite M, Chung L, Rudd C, et al. Investigating the efficacy of cognitive behavioural therapy on improving the mental health of chronic obstructive pulmonary disease patients: a randomised control trial. Respirology. 2015; Vol. 20:35 (TO 057). 5322108
29. Phan T, Carter O, Waterer G, Chung LP, Hawkins M, Rudd C. 'Breathing New Life: Investigating ways to improve the mental health of people living with chronic obstructive pulmonary disease' research study. Unpublished manuscript. 5322109
30. Shao LZ. Effects of the behavioral intervention on the life quality of the patients with chronic obstructive pulmonary disease in remission period. Zhonghua Linchuang Kangfu Zazhi 2003;7(30):4078-9. 5322111
31. ACTRN12612000254897 . Telephone Cognitive Behavioural Therapy for the treatment of depression and anxiety associated with chronic obstructive pulmonary disease: a pragmatic randomised controlled trial. www.anzctr.org.au/ACTRN12612000254897.aspx 2012 (first received 14th of August 2015). 5322113
32. ACTRN12614000915651 . Randomised controlled trial of a brief telephone based cognitive behavioural therapy (CBT) for patients with chronic lung disease and anxiety and/or depression undergoing pulmonary rehabilitation to evaluate the effect on quality of life, symptoms of anxiety and depression, and exacerbation rate. www.anzctr.org.au/ACTRN12614000915651.aspx 2014 (first received 14th of August 2015). 5322115
33. Altman DG, Bland JM. Statistics notes. Units of analysis. BMJ 1997;314:1874.
34. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
35. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest 2013;144(3):766-77.
36. Beck AT, Steer RA. Beck Anxiety Inventory: A Manual. 2nd Edition. San Antonio, TX: Psychological Corporation, 1993.
37. Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Education and Counseling 2011;83:29-36. [DOI: 10.1016/j.pec.2010.04.010]
38. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561-71.
39. Beck JG, Scott SK, Teague RB, Perez LI, Brown GA. Correlates of daily impairment in COPD. Rehabilitation Psychology 1988;33:77-84.
40. Borg GA. Psychophysical basis of perceived exertion. Medicine and Science in Sports and Exercise 1982;14:377-81.
41. Borson S, Claypoole K, McDonald GJ. Depression and chronic obstructive pulmonary disease: treatment trials. Seminars in Clinical Neuropsychiatry 1998;3:115-30.
42. Breland JY, Hundt NE, Barrera TL, Mignogna J, Petersen NJ, Stanley MA. Identification of anxiety symptom clusters in patients with COPD: implications for assessment and treatment. International Journal of Behavioral Medicine 2015 [E-pub ahead of print]:1-8.
43. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment. Psychosomatic Medicine 2003;65:963-70.
44. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. British Medical Journal 1982;284(6329):1607-8.
45. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster-randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action) Health Services Research Unit, University of Aberdeen, UK. Journal of Health Services Research and Policy Jan 2000;5(1):12-16.
46. Clark D. A cognitive approach to panic. Behavior Research and Therapy 1986;24:461-70.
47. Coventry P, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Journal of Psychosomatic Research 2007;63:551-65.
48. Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. Plos One 2013;8(4):e60532.
49. Davison GC, Neale JM. Abnormal Psychology. New York: John Wiley & Sons, 2003.
50. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
51. Di Marco F, Verga M, Reggenta M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respiratory Medicine 2006;100(10):1767-74.
52. DiNicola G, Julian L, Gregorich SE, Blanc PD, Katz PP. The role of social support in anxiety for persons with COPD. Journal of Psychosomatic Research 2013;74(2):110-5.
53. Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, et al. Influence of anxiety on health outcomes in COPD. Thorax 2010;65:229-34.
54. Elassal G, Elsheikh M, Abu Zeid AG. Assessment of depression and anxiety symptoms in chronic obstructive pulmonary disease patients: a case-control study. Egyptian Journal of Chest Diseases and Tuberculosis 2014;63(3):575-82.
55. Gillis MM, Haaga DAF, Ford GT. Normative values for the Beck Anxiety Inventory, Fear Questionnaire, Penn State Worry Questionnaire, and Social Phobia and Anxiety Inventory. Psychological Assessment 1995;7(4):450-5.
56. Global Initiative for Chronic Obstructive Lung Disease Inc. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. www.goldcopd.org/uploads/users/files/GOLD_AtAGlance:2013_Feb20.pdf (accessed 23 July 2013).
57. Schünemann H, Brozek J, Guyatt G, Oxman A, editor(s), GRADE working group. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. gdt.guidelinedevelopment.org/app/handbook/handbook.html.
58. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. European Respiratory Journal 2005;26(3):414-9.
59. Heslop-Marshall K, De Soyza A. Are we missing anxiety in people with chronic obstructive pulmonary disease (COPD)?. Annals of Depression and Anxiety 2014;1(5):1023.
60. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
61. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
62. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
63. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
64. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respiratory Medicine 1991;85 (Suppl B):25-31.
65. Kandel ER. A new intellectual framework for psychiatry. American Journal of Psychiatry 1998;155:457-69.
66. Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th Edition. Lippincott Williams & Wilkins (LWW), 2009.
67. Keil DC, Stenzel NM, Kuhl K, Vaske I, Mewes R, Rief W, et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chronic Respiratory Disease 2014;11(1):31-40.
68. Kerstjens H, Groen H, Van Der Bij W. Respiratory medicine (clinical review: recent advances). BMJ 2001;323:1349-53.
69. Kim HF, Kuic ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000;41(6):465-71.
70. Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychological Medicine 2001;31:717-23.
71. Laurin C, Moullec G, Bacon SL, Lavoie KL. The impact of psychological distress on exacerbation rates in COPD. Therapeutic Advances in Respiratory Disease 2011;5(1):3-18. [DOI: 10.1177/1753465810382818]
72. Ley R. Agoraphobia, the panic attack and the hyperventilation syndrome. Behaviour Research and Therapy 1985;23:79-81.
73. Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Respiratory Medicine 2010;104(9):1246-53.
74. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD. Chest 2008;134:43S-53S.
75. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nordic Journal of Psychiatry 2004;58(1):65-70. [DOI: 10.1080/08039480310000824]
76. National Institute of Clinical Excellence: Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010, London: National Clinical GuidelineGoogle Scholar.
77. Norweg AM, Whiteson J, Malgady R, Mola A, Rey M. The effectiveness of different combinations of pulmonary rehabilitation program components: a randomised controlled trial. Chest 2005;128:663-72.
78. Nutt DJ, Glue P, Lawsom CW, Wilson S. Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Archives of General Psychiatry 1999;47:917-25.
79. Panagioti M, Scott C, Blakemore A, Coventry PA. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. International Journal of COPD 2014;9:1289-306.
80. Perna G, Caldirola D, Bellodi L. Panic disorder: from respiration to the homeostatic brain. Acta Neuropsychiatrica 2004;16:57-67.
81. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2007;176:532-55.
82. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
83. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation of physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Annals of Internal Medicine 1995;122:823-32.
84. Rose C, Wallace L, Dickson R, Ayres J, Lehman R, Searle Y, et al. The most effective psychologically based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Education and Counseling 2002;47:311-8. [PUBMED: 12135822]
85. Royal College of Physcians, Royal College of Psychiatrists. Smoking and mental health. Royal College of Physicians. Royal College of Physcians, 2013.
86. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
87. Smoller J, Simon N, Polack M, Kradin R, Stern T. Anxiety in patients with pulmonary disease: comorbidity and treatment. Seminars in Clinical Neuropsychiatry 1999;4:84-97.
88. Smoller J, Pollack M, Otto M, Rosenbaum J, Kradin R. Panic, anxiety, dyspnea and respiratory disease. American Journal of Respiratory and Critical Care Medicine 1996;154:6-7.
89. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
90. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
91. Suh S, Ellis RJ, Sollers JJ 3rd, Thayer JF, Yang H, Emery CF. The effect of anxiety on heart rate variability, depression, and sleep in Chronic Obstructive Pulmonary Disease. Journal of Psychosomatic Research 2013;74:407-13.
92. Tan SK, Benedicto J, Santiaguel J. Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: a multi-center study. European Respiratory Journal 2013;42(S57):4183.
93. Usmani ZA, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD008483.pub2]
94. Viinamaki H, Kuikka J, Tiihonen J, Lehtonen J. Change in monoamine transporter density related to clinical recovery: a case control study. Nordic Journal of Psychiatry 1998;52:39-44.
95. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nursing Research 1997;46:26-31.
96. Willgoss T, Yohannes A, Goldbart J, Fatoye F. COPD and anxiety: its impact on patients' lives. Nursing Times 2011;107(15-16):16-9.
97. Wu HS, Wu SC, Lin JG, Lin LC. Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. Journal of Advanced Nursing 2004;45(3):252-9.
98. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. International Journal of Geriatric Psychiatry 2000;15(12):1090-6.
99. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. International Journal of Geriatric Psychiatry 2001;16(5):451-4.
100. Yohannes A, Baldwin R, Connolly M. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age and Ageing 2006;35:457-9.
101. Zigmond AS, Snaith RP. The Hospital Anxiety And Depression Scale. Acta Psychiatrica Scandinavia 1983;67:361-70.
102. Usmani ZA, Carson KV, Heslop K, Esterman AJ, De Soyza A, Smith BJ. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010673]